+
Open data
-
Basic information
| Entry | Database: PDB / ID: 7v26 | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Title | XG005-bound SARS-CoV-2 S | |||||||||||||||||||||||||||
 Components | 
  | |||||||||||||||||||||||||||
 Keywords | VIRAL PROTEIN / SARS-CoC-2 / spike / Antibodies | |||||||||||||||||||||||||||
| Function / homology |  Function and homology informationsymbiont-mediated disruption of host tissue / Maturation of spike protein / Translation of Structural Proteins / Virion Assembly and Release / host cell surface / host extracellular space / viral translation / symbiont-mediated-mediated suppression of host tetherin activity / Induction of Cell-Cell Fusion / structural constituent of virion ...symbiont-mediated disruption of host tissue / Maturation of spike protein / Translation of Structural Proteins / Virion Assembly and Release / host cell surface / host extracellular space / viral translation / symbiont-mediated-mediated suppression of host tetherin activity / Induction of Cell-Cell Fusion / structural constituent of virion / entry receptor-mediated virion attachment to host cell / membrane fusion / Attachment and Entry / host cell endoplasmic reticulum-Golgi intermediate compartment membrane / positive regulation of viral entry into host cell / receptor-mediated virion attachment to host cell / host cell surface receptor binding / symbiont-mediated suppression of host innate immune response / receptor ligand activity / endocytosis involved in viral entry into host cell / fusion of virus membrane with host plasma membrane / fusion of virus membrane with host endosome membrane / viral envelope / symbiont entry into host cell / virion attachment to host cell / SARS-CoV-2 activates/modulates innate and adaptive immune responses / host cell plasma membrane / virion membrane / identical protein binding / membrane / plasma membrane Similarity search - Function  | |||||||||||||||||||||||||||
| Biological species | ![]()  Homo sapiens (human) | |||||||||||||||||||||||||||
| Method | ELECTRON MICROSCOPY / single particle reconstruction / cryo EM / Resolution: 3.85 Å | |||||||||||||||||||||||||||
 Authors | Zhan, W.Q. / Zhang, X. / Sun, L. / Chen, Z.G. | |||||||||||||||||||||||||||
| Funding support |   China, 1items 
  | |||||||||||||||||||||||||||
 Citation |  Journal: Protein Cell / Year: 2022Title: An ultrapotent pan-β-coronavirus lineage B (β-CoV-B) neutralizing antibody locks the receptor-binding domain in closed conformation by targeting its conserved epitope. Authors: Zezhong Liu / Wei Xu / Zhenguo Chen / Wangjun Fu / Wuqiang Zhan / Yidan Gao / Jie Zhou / Yunjiao Zhou / Jianbo Wu / Qian Wang / Xiang Zhang / Aihua Hao / Wei Wu / Qianqian Zhang / Yaming Li ...Authors: Zezhong Liu / Wei Xu / Zhenguo Chen / Wangjun Fu / Wuqiang Zhan / Yidan Gao / Jie Zhou / Yunjiao Zhou / Jianbo Wu / Qian Wang / Xiang Zhang / Aihua Hao / Wei Wu / Qianqian Zhang / Yaming Li / Kaiyue Fan / Ruihong Chen / Qiaochu Jiang / Christian T Mayer / Till Schoofs / Youhua Xie / Shibo Jiang / Yumei Wen / Zhenghong Yuan / Kang Wang / Lu Lu / Lei Sun / Qiao Wang /     ![]() Abstract: New threats posed by the emerging circulating variants of SARS-CoV-2 highlight the need to find conserved neutralizing epitopes for therapeutic antibodies and efficient vaccine design. Here, we ...New threats posed by the emerging circulating variants of SARS-CoV-2 highlight the need to find conserved neutralizing epitopes for therapeutic antibodies and efficient vaccine design. Here, we identified a receptor-binding domain (RBD)-binding antibody, XG014, which potently neutralizes β-coronavirus lineage B (β-CoV-B), including SARS-CoV-2, its circulating variants, SARS-CoV and bat SARSr-CoV WIV1. Interestingly, antibody family members competing with XG014 binding show reduced levels of cross-reactivity and induce antibody-dependent SARS-CoV-2 spike (S) protein-mediated cell-cell fusion, suggesting a unique mode of recognition by XG014. Structural analyses reveal that XG014 recognizes a conserved epitope outside the ACE2 binding site and completely locks RBD in the non-functional "down" conformation, while its family member XG005 directly competes with ACE2 binding and position the RBD "up". Single administration of XG014 is effective in protection against and therapy of SARS-CoV-2 infection in vivo. Our findings suggest the potential to develop XG014 as pan-β-CoV-B therapeutics and the importance of the XG014 conserved antigenic epitope for designing broadly protective vaccines against β-CoV-B and newly emerging SARS-CoV-2 variants of concern.  | |||||||||||||||||||||||||||
| History | 
  | 
-
Structure visualization
| Movie | 
 
  Movie viewer | 
|---|---|
| Structure viewer | Molecule:  Molmil Jmol/JSmol | 
-
Downloads & links
-
Download
| PDBx/mmCIF format |  7v26.cif.gz | 780.7 KB | Display |  PDBx/mmCIF format | 
|---|---|---|---|---|
| PDB format |  pdb7v26.ent.gz | 640 KB | Display |  PDB format | 
| PDBx/mmJSON format |  7v26.json.gz | Tree view |  PDBx/mmJSON format | |
| Others |  Other downloads | 
-Validation report
| Summary document |  7v26_validation.pdf.gz | 824.2 KB | Display |  wwPDB validaton report | 
|---|---|---|---|---|
| Full document |  7v26_full_validation.pdf.gz | 877.3 KB | Display | |
| Data in XML |  7v26_validation.xml.gz | 113.9 KB | Display | |
| Data in CIF |  7v26_validation.cif.gz | 176 KB | Display | |
| Arichive directory |  https://data.pdbj.org/pub/pdb/validation_reports/v2/7v26 ftp://data.pdbj.org/pub/pdb/validation_reports/v2/7v26 | HTTPS FTP  | 
-Related structure data
| Related structure data | ![]() 31637MC ![]() 7v2aC M: map data used to model this data C: citing same article (  | 
|---|---|
| Similar structure data | 
-
Links
-
Assembly
| Deposited unit | ![]() 
  | 
|---|---|
| 1 | 
  | 
-
Components
| #1: Protein | Mass: 142319.219 Da / Num. of mol.: 3 / Mutation: R682G, R683S, R685S, K986P, V987P Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() Gene: S, 2 / Cell line (production host): 293F / Production host:  Homo sapiens (human) / References: UniProt: P0DTC2#2: Antibody | Mass: 24894.102 Da / Num. of mol.: 3 Source method: isolated from a genetically manipulated source Source: (gene. exp.)  Homo sapiens (human) / Cell line (production host): 293F / Production host:  Homo sapiens (human)#3: Antibody | Mass: 22650.992 Da / Num. of mol.: 3 Source method: isolated from a genetically manipulated source Source: (gene. exp.)  Homo sapiens (human) / Cell line (production host): 293F / Production host:  Homo sapiens (human)#4: Sugar | ChemComp-NAG / Has ligand of interest | N | Has protein modification | Y |  | 
|---|
-Experimental details
-Experiment
| Experiment | Method: ELECTRON MICROSCOPY | 
|---|---|
| EM experiment | Aggregation state: PARTICLE / 3D reconstruction method: single particle reconstruction | 
-
Sample preparation
| Component | 
  | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Source (natural) | 
  | ||||||||||||||||||||||||
| Source (recombinant) | 
  | ||||||||||||||||||||||||
| Buffer solution | pH: 7 | ||||||||||||||||||||||||
| Specimen | Embedding applied: NO / Shadowing applied: NO / Staining applied: NO / Vitrification applied: YES | ||||||||||||||||||||||||
| Vitrification | Cryogen name: ETHANE | 
-
Electron microscopy imaging
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company  | 
|---|---|
| Microscopy | Model: FEI TITAN KRIOS | 
| Electron gun | Electron source:  FIELD EMISSION GUN / Accelerating voltage: 300 kV / Illumination mode: FLOOD BEAM | 
| Electron lens | Mode: BRIGHT FIELD | 
| Image recording | Electron dose: 53 e/Å2 / Film or detector model: GATAN K2 QUANTUM (4k x 4k) | 
-
Processing
| Software | Name: PHENIX / Version: 1.17.1_3660: / Classification: refinement | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EM software | Name: PHENIX / Category: model refinement | ||||||||||||||||||||||||
| CTF correction | Type: PHASE FLIPPING AND AMPLITUDE CORRECTION | ||||||||||||||||||||||||
| 3D reconstruction | Resolution: 3.85 Å / Resolution method: FSC 0.143 CUT-OFF / Num. of particles: 109304 / Symmetry type: POINT | ||||||||||||||||||||||||
| Refine LS restraints | 
  | 
Movie
Controller
About Yorodumi





Homo sapiens (human)
China, 1items 
Citation
 
UCSF Chimera










PDBj







